We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+1.75%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$273M
AUM Growth
+$47.2M
Cap. Flow
-$2.26M
Cap. Flow %
-0.83%
Top 10 Hldgs %
20.26%
Holding
132
New
11
Increased
32
Reduced
38
Closed
7

Top Buys

Rank Stock Value
1
YELP icon
Yelp
YELP
+$2.28M
2
CARG icon
CarGurus
CARG
+$2.09M
3
DOMO icon
Domo
DOMO
+$1.97M
4
ALLO icon
Allogene Therapeutics
ALLO
+$1.8M
5
AVLR
Avalara, Inc.
AVLR
+$1.8M

Top Sells

Rank Stock Value
1
CVNA icon
Carvana
CVNA
+$1.79M
2
OKTA icon
Okta
OKTA
+$1.62M
3
ROKU icon
Roku
ROKU
+$1.54M
4
TTSH
Tile Shop Holdings
TTSH
+$1.47M
5
PE
PARSLEY ENERGY INC
PE
+$1.42M

Sector Composition

Rank Sector Weight
1 Technology 27.39%
2 Healthcare 21.65%
3 Communication Services 12.48%
4 Consumer Discretionary 10.05%
5 Financials 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
26
Synopsys
SNPS
$71.5B
$2.36M 0.87%
18,804
AYX
27
DELISTED
Alteryx Inc
AYX
$2.36M 0.86%
21,947
-9,610
-30% -$875K
REGN icon
28
Regeneron Pharmaceuticals
REGN
$68.8B
$2.35M 0.86%
7,582
TREE icon
29
LendingTree
TREE
$544M
$2.33M 0.85%
5,531
-2,592
-32% -$992K
MMSI icon
30
Merit Medical Systems
MMSI
$4.43B
$2.28M 0.84%
38,469
+3,692
+11% +$212K
OLLI icon
31
Ollie's Bargain Outlet
OLLI
$4.01B
$2.27M 0.83%
25,800
+241
+0.9% +$22.7K
TXRH icon
32
Texas Roadhouse
TXRH
$12.7B
$2.25M 0.82%
41,342
+5,213
+14% +$293K
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$2.65B
$2.24M 0.82%
36,165
-1,693
-4% -$108K
UTHR icon
34
United Therapeutics
UTHR
$26.3B
$2.24M 0.82%
29,096
+7,394
+34% +$691K
ROKU icon
35
Roku
ROKU
$21.1B
$2.24M 0.82%
23,991
-19,183
-44% -$1.54M
YELP icon
36
Yelp
YELP
$1.38B
$2.24M 0.82%
+65,871
New +$2.28M
CERN
37
DELISTED
Cerner Corp
CERN
$2.21M 0.81%
30,773
WWE
38
DELISTED
World Wrestling Entertainment
WWE
$2.2M 0.81%
30,449
-1,035
-3% -$84.8K
MTDR icon
39
Matador Resources
MTDR
$6.31B
$2.16M 0.79%
113,495
+32,513
+40% +$617K
MEDP icon
40
Medpace
MEDP
$16.8B
$2.16M 0.79%
33,680
+835
+3% +$48.1K
GBT
41
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.15M 0.79%
39,866
-11,686
-23% -$672K
NEWR
42
DELISTED
New Relic, Inc.
NEWR
$2.11M 0.77%
24,143
-1,867
-7% -$184K
CCOI icon
43
Cogent Communications
CCOI
$594M
$2.06M 0.75%
34,674
-4,254
-11% -$244K
TTEC icon
44
TTEC Holdings
TTEC
$103M
$2.05M 0.75%
44,735
-11,370
-20% -$439K
CORT icon
45
Corcept Therapeutics
CORT
$10.2B
$2.04M 0.75%
183,470
-10,224
-5% -$114K
JJSF icon
46
J&J Snack Foods
JJSF
$1.43B
$2.04M 0.75%
12,704
-68
-0.5% -$10.9K
MC icon
47
Moelis & Co
MC
$4.98B
$2.04M 0.75%
58,956
+12,348
+26% +$447K
GHDX
48
DELISTED
Genomic Health, Inc.
GHDX
$2.02M 0.74%
35,942
+11,277
+46% +$668K
KURA icon
49
Kura Oncology
KURA
$922M
$2.02M 0.74%
102,198
-34,569
-25% -$574K
BOX icon
50
Box
BOX
$4.02B
$2.02M 0.74%
115,085
+4,905
+4% +$93.8K

Similar funds

Capital Impact Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Capital Impact Advisors held 132 positions worth $273M, up 21% from $226M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Capital Impact Advisors's Q2 2019 filing shows 11 new, 32 increased, 38 reduced and 7 closed positions. Its largest new stake was Yelp: 65,871 shares worth $2.24M. The largest sale was Carvana, an estimated $1.79M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q2 2019 buy was Yelp: 65,871 shares worth $2.24M.
  • Capital Impact Advisors added most to Puma Biotechnology in Q2 2019, an estimated $1.22M increase.
  • Capital Impact Advisors's biggest Q2 2019 reduction was Okta, cutting an estimated $1.62M.
  • Capital Impact Advisors fully exited Carvana in Q2 2019, selling an estimated $1.79M.
  • Capital Impact Advisors's ten largest holdings make up 20% of its $273M portfolio in Q2 2019.
  • Capital Impact Advisors opened 11 new positions and closed 7 in Q2 2019.
  • Capital Impact Advisors's portfolio value rose 21% quarter-over-quarter to $273M.

Based on Capital Impact Advisors's 13F filing for Q2 2019, filed 19 Jul 2019.